You are here
The purpose of the Shadow Pricing Guidelines is to provide guidance for the use of shadow pricing in the development and implementation of changes to classification systems. The Shadow Pricing Guidelines establishes guiding principles for commencing shadow pricing, reporting requirements during the shadow pricing period and criteria for progression to pricing.
The Back-casting Policy outlines the process the Independent Hospital Pricing Authority follows when back-casting the national efficient price or national efficient cost to enable calculation of the Commonwealth’s funding contribution, as set out in the Addendum to the National Health Reform Agreement 2020–25 (clause A41).
Each year, the Independent Hospital Pricing Authority (IHPA) publishes the General List of In-Scope Public Hospital Services (the General List) as part of the National Efficient Price Determination. The General List defines public hospital services eligible for Commonwealth funding, except where funding is otherwise agreed between the Commonwealth and a state or territory.
The Independent Hospital Pricing Authority Work Program and Corporate Plan 2021–22 has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011 and section 35(1)(b) of the Public Governance, Performance and Accountability Act 2013 for the reporting periods 2021–22 to 2023–24.
The Assessing Materiality of Changes Proposed to the National Pricing Model document outlines the process the Independent Hospital Pricing Authority follows when assessing the materiality of proposed refinements to the national pricing model, such as new adjustments for specific cohorts of patients or the application of modified pricing approaches.
A jurisdiction may request the Independent Hospital Pricing Authority (IHPA) to consider any legitimate and unavoidable costs in the delivery of public hospital services. The purpose of this Framework is to outline the process by which IHPA will assess submissions from jurisdictions on legitimate and unavoidable cost variations and determine whether adjustments to the national efficient price are warranted.
This Framework outlines the processes to investigate cross-border and cost-shifting disputes following a request by a health minister to ensure the timely, equitable and transparent management of these disputes.
The Independent Hospital Pricing Authority (IHPA) is responsible for relevant data collections to enable activity based funding. IHPA’s Data Access and Release Policy outlines the principles and processes adopted by IHPA in the discretionary access and release of data collected under the National Health Reform Act 2011. The Policy provides guidance as to how IHPA will determine whether to release data.
This Policy outlines the processes by which the Independent Hospital Pricing Authority stabilises volatility in the year-on-year price weights and adjustments to ensure funding stability and predictability for local hospital networks and hospital managers.
The Pricing Framework for Australian Public Hospital Services 2021–22 (the Pricing Framework) is the key strategic document underpinning the national efficient price (NEP) and national efficient cost (NEC) Determinations for the financial year 2021–22 (NEP21 and NEC21 respectively).
As prescribed in Section 225 of the National Health Reform Act 2011 (the Act), the objectives of the IHPA Work Program are to:
- set out IHPA’s work program for the coming year; and
- invite interested persons (including states and territories) to make submissions to the Pricing Authority about the work program up to 30 days after publication.
An extract of Section 225 of the Act is attached at Appendix 1